The Scal atrial natriuretic peptide gene polymorphism is associated with nonfatal myocardial infarction and extent of coronary artery disease

被引：0
|
作者：
Gruchala, M. [1 ]
Sobiczewski, W. [1 ]
Targonski, R. [1 ]
Rynkiewicz, A. [1 ]
机构：
[1] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2033
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [31] A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy
    Schmidt, S
    Bluthner, M
    Giessel, R
    Strojek, K
    Bergis, KH
    Grzeszczak, W
    Ritz, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) : 1807 - 1810
  • [32] B-type natriuretic peptide is an independent predictor of the extent of coronary artery disease
    Kragelund, C
    Estensen, ME
    Vik-Mo, H
    Omland, T
    CIRCULATION, 2004, 110 (17) : 356 - 356
  • [33] HpaII polymorphism in the atrial natriuretic peptide gene and hypertension
    Cheung, BMY
    Leung, R
    Shiu, S
    Tan, KCB
    Lau, CP
    Kumana, CR
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (05) : 524 - 527
  • [34] Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]
    Olesen, Kevin KrisWarnakula
    Gyldenkerne, Christine
    Madsen, Morten
    Thim, Troels
    Jensen, Lisette Okkels
    Raungaard, Bent
    Sorensen, Henrik Toft
    Botker, Hans Erik
    Maeng, Michael
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 721 - 722
  • [35] Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
    Gardemann, A
    Humme, J
    Stricker, J
    Nguyen, QD
    Katz, N
    Philipp, M
    Tillmanns, H
    Hehrlein, FW
    Rau, M
    Haberbosch, W
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 214 - 217
  • [36] Influence of the I/D ACE polymorphism and A1166C AT1R polymorphism interaction on the risk of nonfatal myocardial infarction, extent of coronary artery disease and family CAD history in males
    Ciecwierz, D
    Nowak, A
    Gruchala, M
    Skarzynski, P
    Dubaniewicz, W
    Targonski, R
    Wasag, B
    Ochman, K
    Rynkiewicz, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 161 - 161
  • [37] B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease
    Sahinarslan, A
    Cengel, A
    Okyay, K
    Yazici, HU
    Elbey, S
    Cemri, M
    Ozdemir, M
    Timurkaynak, T
    CORONARY ARTERY DISEASE, 2005, 16 (04) : 225 - 229
  • [38] SMOKING, CORONARY-ARTERY OCCLUSION, AND NONFATAL MYOCARDIAL-INFARCTION
    HARTZ, AJ
    BARBORIAK, PN
    ANDERSON, AJ
    HOFFMANN, RG
    BARBORIAK, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (08): : 851 - 853
  • [39] ATRIAL-NATRIURETIC-PEPTIDE IN MYOCARDIAL-INFARCTION - REPLY
    RECTOR, TS
    COHN, JN
    AMERICAN HEART JOURNAL, 1987, 113 (06) : 1532 - 1532
  • [40] Specific roles for atrial natriuretic peptide and brain natriuretic peptide as biomarkers in left ventricular dysfunction and coronary artery disease
    Martin, FL
    Cataliotti, A
    Lee, SC
    Schirger, JA
    Heublein, DM
    Boerrigter, LCC
    Boerrigter, G
    Burnett, JC
    EUROPEAN HEART JOURNAL, 2004, 25 : 338 - 338
12345